PHAT NASDAQ
Phathom Pharmaceuticals, Inc.
1W: -11.3%
1M: -1.3%
3M: +1.4%
YTD: -26.3%
1Y: +164.4%
3Y: -7.4%
5Y: -65.2%
$11.33
-0.25 (-2.16%)
Weekly Expected Move ±10.2%
$9
$11
$12
$13
$14
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$205M
Revenue
+150.3% YoY
$-157M
Net Income
+54.5% YoY
$-97M
Free Cash Flow
+65.6% YoY
79.4%
Gross Margin
-26.5%
Op. Margin
-52.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE45.5%
ROA-49.4%
ROIC13.5%
Valuation
P/E-5.9
P/B-2.8
EV/EBITDA-8.4
Leverage
Debt/Equity-0.01
Current Ratio1.73
Interest Cov.-1.4x
Quality Scores
Piotroski F3/9
Altman Z-7.19
Beneish M-2.05